
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)’s Biologics License Application for Natpara To Be Taken Up By Food And Drug Administration Committee
Boston, MA 09/11/2014 (wallstreetpr) – Biopharmaceutical company focused on delivering therapies, NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) disclosed that the Food and Drug Administration in the U.S.













